Skip to main content
Swedish Orphan Biovitrum logo

Swedish Orphan Biovitrum — Investor Relations & Filings

Ticker · SOBI ISIN · SE0000872095 LEI · 549300124Y3MQI87PT35 ST Manufacturing
Open in API
Filings indexed 892 across all filing types
Latest filing 2016-04-27 Interim / Quarterly Rep…
Country SE Sweden
Listing ST SOBI

About Swedish Orphan Biovitrum

https://www.sobi.com/en

Swedish Orphan Biovitrum (Sobi) is a specialized biopharmaceutical company dedicated to developing and delivering innovative treatments for rare and debilitating diseases. The company's primary focus is on the therapeutic areas of haematology and immunology, with a significant legacy and continued leadership in haemophilia care. Sobi addresses the high unmet medical needs of patients by advancing a pipeline of innovative medicines and working to expand patient access globally. The company's mission is to transform the lives of people affected by rare conditions through dedicated research, development, and global collaboration.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2016
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for the period January-March 2016. It contains comprehensive financial statements, including income statements, cash flow analysis, and detailed breakdowns of revenue by product area (Inflammation, Genetics & Metabolism, Haemophilia, etc.). It is not an announcement of a report, but the report itself, containing substantive financial data and management commentary. Therefore, it fits the definition of an Interim/Quarterly Report. Q1 2016
2016-04-27 Swedish
Interim / Quarterly Report 2016
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Q1 REPORT 2016' and contains comprehensive financial statements, a CEO statement, business reviews, and detailed financial tables for the first quarter of 2016. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2016
2016-04-27 English
Sobi publishes its report for the first quarter 2016
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Q1 REPORT 2016' and contains comprehensive financial statements, a CEO statement, business reviews, and detailed financial tables for the first quarter of 2016. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2016
2016-04-27 English
Sobi publicerar sin rapport för första kvartalet 2016
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for the period January-March 2016. It contains comprehensive financial statements, including income statements, cash flow analysis, and detailed breakdowns of revenue by product area (Inflammation, Genetics & Metabolism, Haemophilia, etc.). It is not an announcement of a report, but the report itself, containing substantive financial data and management commentary. Therefore, it fits the definition of an Interim/Quarterly Report. Q1 2016
2016-04-27 Swedish
Rättelse av kallelse till årsstämma i Swedish Orphan Biovitrum AB (publ) på grund av skrivfel i den svenska versionen av kallelsen
AGM Information Classification · 98% confidence The document is titled "Rättelse av kallelse till årsstämma i Swedish Orphan Biovitrum AB (publ)" (Correction of the notice of the Annual General Meeting in Swedish Orphan Biovitrum AB (publ)). It details the date, time, location, registration procedures, and the proposed agenda for the upcoming general meeting, including specific items like the election of board members and remuneration proposals. This content is characteristic of materials related to an Annual General Meeting (AGM). Although it contains remuneration proposals (which might suggest DEF 14A), the primary context and structure are that of a formal notice and agenda for the AGM itself. Therefore, the most appropriate classification is AGM-R (AGM Information).
2016-04-22 Swedish
Kallelse till årsstämma i Swedish Orphan Biovitrum AB (publ)
AGM Information Classification · 98% confidence The document is titled "Kallelse till årsstämma i Swedish Orphan Biovitrum AB (publ)" which translates to 'Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ)'. It details the date, time, location, registration procedures, proposed agenda items (including election of directors, approval of remuneration, and capital structure proposals), and specific recommendations from the Nomination Committee regarding board composition and remuneration. This content is characteristic of a formal notice and materials distributed for an Annual General Meeting (AGM). Although it contains remuneration details (which might suggest DEF 14A), the primary purpose and structure are clearly centered around convening and setting the agenda for the AGM. Therefore, the most appropriate classification is AGM Information (AGM-R). The document length (42,307 chars) is substantial, indicating it is the full notice/material, not just a brief announcement (RPA).
2016-04-20 Swedish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.